Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases

Neurotransmitter depletion and mitochondrial dysfunction are among the multiple pathological events that lead to neurodegeneration. Following our previous studies related with the development of multitarget mitochondriotropic antioxidants, this study aims to evaluate whether the π-system extension o...

Full description

Bibliographic Details
Main Authors:	Daniel Chavarria, Ophelie Da Silva, Sofia Benfeito, Sandra Barreiro, Jorge Garrido, Fernando Cagide, Pedro Soares, Fernando Remião, Xavier Brazzolotto, Florian Nachon, Paulo J. Oliveira, José Dias, Fernanda Borges
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Antioxidants
Subjects:	neurodegenerative diseases piperine triphenylphosphonium cholinesterases monoamine oxidase mitochondria-targeted antioxidants
Online Access:	https://www.mdpi.com/2076-3921/10/2/329

Similar Items

Curcumin–Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders
by: Elías Quezada, et al.
Published: (2021-07-01)

Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors
by: Catarina Oliveira, et al.
Published: (2018-04-01)

A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration
by: Emanuela Berrino, et al.
Published: (2023-11-01)

First Report on Cationic Triphenylphosphonium Compounds as Mitochondriotropic H<sub>3</sub>R Ligands with Antioxidant Properties
by: Tobias Werner, et al.
Published: (2024-11-01)

Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells
by: Ji Hee Kang, et al.
Published: (2019-08-01)

A twenty-year journey exploring coumarin-based derivatives as bioactive molecules
by: Leonardo Pisani, et al.
Published: (2022-10-01)

Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer’s Disease Pathophysiological Hallmarks
by: Sofia Benfeito, et al.
Published: (2020-01-01)

Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer’s disease agents
by: Sheunopa C. Mzezewa, et al.
Published: (2021-01-01)

Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor α
by: Ludmila A. Zinovkina, et al.
Published: (2020-03-01)

Nutraceutical Potential of Phenolics from ′Brava′ and ′Mansa′ Extra-Virgin Olive Oils on the Inhibition of Enzymes Associated to Neurodegenerative Disorders in Comparison with Those of ′Picual′ and ′Cornicabra′
by: María Figueiredo-González, et al.
Published: (2018-03-01)

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease
by: Huang ST, et al.
Published: (2024-01-01)

In Vitro Effect of Mitochondria-Targeted Triphenylphosphonium-Based Compounds (Honokiol, Lonidamine, and Atovaquone) on the Platelet Function and Cytotoxic Activity
by: Héctor Montecino-Garrido, et al.
Published: (2022-05-01)

Identification of Novel Multifunctional Compounds for the Treatment of Some Aging Related Neurodegenerative Diseases
by: Laura Novaroli, et al.
Published: (2005-06-01)

Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease
by: Donia E. Hafez, et al.
Published: (2023-12-01)

A review on coumarin backbone: An attractive scaffold for promising bioactive compounds
by: Sara Jasim, et al.
Published: (2022-01-01)

Dual Effect of Alternariol on Acetyl Cholinesterase and Monoamineoxidase Extracted from Different Parts of Rat Brain
by: Hassan M.Y. Osman, et al.
Published: (2008-12-01)

The Use of Triphenyl Phosphonium Cation Enhances the Mitochondrial Antiplatelet Effect of the Compound Magnolol
by: Francisca Tellería, et al.
Published: (2023-01-01)

Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders
by: Priyanka Dhiman, et al.
Published: (2019-01-01)

Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles
by: Miguel Pinto, et al.
Published: (2019-07-01)

<i>N</i>-Hydroxy-<i>N</i>-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
by: Óscar M. Bautista-Aguilera, et al.
Published: (2022-11-01)

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
by: Zofia Chrienova, et al.
Published: (2022-12-01)

Effect of Hydroxytyrosol Derivatives of Donepezil on the Activity of Enzymes Involved in Neurodegenerative Diseases and Oxidative Damage
by: Antonio D’Errico, et al.
Published: (2024-01-01)

Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases?
by: Simone Carradori, et al.
Published: (2022-11-01)

Natural based piperine derivatives as potent monoamine oxidase inhibitors: an in silico ADMET analysis and molecular docking studies
by: Priyanka Dhiman, et al.
Published: (2020-02-01)

Linking triphenylphosphonium cation to a bicyclic hydroquinone improves their antiplatelet effect via the regulation of mitochondrial function
by: Diego Méndez, et al.
Published: (2024-06-01)

Inhibition of Butyrylcholinesterase and Human Monoamine Oxidase-B by the Coumarin Glycyrol and Liquiritigenin Isolated from <i>Glycyrrhiza uralensis</i>
by: Geum Seok Jeong, et al.
Published: (2020-08-01)

(<i>S</i>)-<i>N</i>-Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1<i>H</i>)-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity
by: Qing-Hao Jin, et al.
Published: (2023-02-01)

Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents
by: Jie Yang, et al.
Published: (2019-01-01)

Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site
by: Rati K. P. Tripathi, et al.
Published: (2018-01-01)

A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity
by: Katerina N. Panagiotaki, et al.
Published: (2017-11-01)

Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases
by: Leysan Vasileva, et al.
Published: (2023-10-01)

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
by: Damijan Knez, et al.
Published: (2023-05-01)

Identification of neurotherapeutic constituents in Ocimum gratissimum with cholinesterase and mono amine oxidase inhibitory activities, using GC-MS analysis, in vitro, and in silico approaches
by: Anoka A. Njan, et al.
Published: (2023-01-01)

Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as potential anti-Alzheimer’s disease agents
by: Jie Yang, et al.
Published: (2020-01-01)

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
by: Samina Khan Yusufzai, et al.
Published: (2018-12-01)

Ageing and Neurodegeneration – The Role of Neurotransmitters’ Activity
by: Bonka Lozanska, et al.
Published: (2022-12-01)

Hospitalized Patients' Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist's Classroom-Based Education
by: Richard G. Wenzel, et al.
Published: (2010-06-01)

Novas estratégias terapêuticas para o tratamento da depressão: uma visão da química medicinal
by: Romeiro Luiz Antonio Soares, et al.
Published: (2003-01-01)

Identification of New <i>N</i>-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
by: Ashraf K. El-Damasy, et al.
Published: (2023-01-01)

Design, Synthesis and Biological Evaluation of New 3,4-Dihydro-2(1H)-Quinolinone-Dithiocarbamate Derivatives as Multifunctional Agents for the Treatment of Alzheimer’s Disease
by: Guo J, et al.
Published: (2022-05-01)